| |
Normal subjects (n = 30)
|
ESRD with targeted iPTH (n = 32)
|
ESRD with increased iPTH (n = 40)
|
|---|
|
LV function
| | | |
|
EF (%)
|
65.0 ± 4.5
|
55.9 ± 12.0*
|
51.7 ± 12.8*
|
|
EDV (mL)
|
117 ± 31
|
128 ± 44
|
134 ± 50
|
|
ESV (mL)
|
45 ± 13
|
60 ± 44
|
69 ± 47*
|
|
SV (mL)
|
79 ± 17
|
67 ± 18
|
65 ± 18
|
|
LV mass (g)
|
52 ± 17
|
85 ± 31*
|
90 ± 32*
|
|
EDV/BSA (mL/mm2)
|
72.3 ± 20.1
|
83.3 ± 26.4
|
84.8 ± 36.3
|
|
ESV/BSA (mL/m2)
|
260.0 ± 5.5
|
38.9 ± 26.4
|
43.8 ± 34.4 *
|
|
SV/BSA (mL/m2)
|
48.6 ± 11.2
|
44.2 ± 11.6
|
40.3 ± 10.9*
|
|
Mass/BSA (g/m2)
|
32.2 ± 11.4
|
54.4 ± 19.0*
|
56.3 ± 19.0*
|
|
Myocardial strain parameters
| | | |
|
PRS
|
43.0 ± 9.8
|
43.2 ± 14.9
|
37.6 ± 15.7
|
|
PCS
|
− 18.3 ± 2.1
|
− 17.8 ± 4.2
|
− 16.8 ± 5.0
|
|
PLS
|
− 16.5 ± 2.4
|
− 15.7 ± 3.7
|
− 14.8 ± 4.4
|
|
Native T1 value
| | | |
|
Basal segment
|
1238 ± 36
|
1304 ± 41*
|
1330 ± 43*#
|
|
Middle segment
|
1242 ± 50
|
1300 ± 43*
|
1323 ± 43*#
|
|
Apical segment
|
1280 ± 65
|
1339 ± 86
|
1360 ± 74*
|
|
Global
|
1251 ± 49
|
1305 ± 41*
|
1334 ± 40*#
|
- LV left ventricular, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, SV stroke volume, PRS peak radial strain, PCS peak circumferential strain, PLS peak longitudinal strain directions, BSA body surface area. Other abbreviations are the same as Tables 1 and 2
- *P < 0.05 vs. normal group; #P < 0.05 vs. comparison with ESRD with targeted iPTH
